Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone

被引：0
|
作者：
Oliver Kummer
Felix Hammann
Claudine Moser
Olivier Schaller
Jürgen Drewe
Stephan Krähenbühl
机构：
[1] University Hospital,Division of Clinical Pharmacology and Toxicology, Department of Biomedicine
[2] Mundipharma Medical Company,undefined
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Oxycodone; Ketoconazole; Paroxetine; Drug interactions; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：63 / 71
页数：8
相关论文
共 50 条
  • [1] Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
    Kummer, Oliver
    Hammann, Felix
    Moser, Claudine
    Schaller, Olivier
    Drewe, Juergen
    Kraehenbuehl, Stephan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (01) : 63 - 71
  • [2] Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
    Heiskanen, T
    Olkkola, KT
    Kalso, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (06) : 603 - 611
  • [3] Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4
    Gronlund, Juha
    Saari, Teijo I.
    Hagelberg, Nora
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    Laine, Kari
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1063 - 1067
  • [4] Influence of CYP3A4 and CYP2D6 inhibition on fesoterodine treatment
    Sachse, R
    Cawello, W
    Horstmann, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1186 - 1186
  • [5] Determinant role of CYP2D6 and CYP3A4 pathways on the antinociceptive effects of oxycodone.
    Samer, C
    Daali, Y
    Rebsamen, M
    Chiappe, A
    Desmeules, J
    Dayer, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P57 - P57
  • [6] Exposure to oral oxycodone is increased by simultaneous inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
    Gronlund, J.
    Hagelberg, N.
    Saari, T.
    Neuvonen, P.
    Olkkola, K.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2010, 27 (01) : 144 - 144
  • [7] Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
    Gronlund, Juha
    Saari, Teijo I.
    Hagelberg, Nora M.
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    Laine, Kari
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (01) : 78 - 87
  • [8] Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol
    Fang, J
    Baker, GB
    Silverstone, PH
    Coutts, RT
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1997, 17 (02) : 227 - 233
  • [9] Involvement of CYP3A4 and CYP2D6 in the Metabolism of Haloperidol
    Jian Fang
    Glen B. Baker
    Peter H. Silverstone
    Ronald T. Coutts
    Cellular and Molecular Neurobiology, 1997, 17 : 227 - 233
  • [10] Influence of CYP2D6, CYP3A4 and CYP3A5 genotypes on the pharmacokinetics of bropmeridol and extrapyramidal symptoms
    Lee, SY
    Kim, YG
    Kim, HG
    Kim, JW
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 232 - 232
12345